Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

SCAI pushes for better radiation protection in cath labs
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.
Tracking major trends and clinical research in acute coronary syndrome care
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials
Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment.

SCAI 2021: 98% of new TAVR programs developed in metropolitan areas

Researchers tracked 554 TAVR programs that opened from 2012 to 2018, sharing their findings at the SCAI 2021 Scientific Sessions.

SCAI 2021: COVID-19 especially harmful for high-risk heart attack patients

Researchers presented new data from the North American COVID-19 Myocardial Infarction registry, detailing the ongoing pandemic's "deadly impact."

SCAI unveils new cath lab guidelines at annual meeting

The new guidelines were endorsed by the American College of Cardiology, American Heart Association, Heart Rhythm Society and Clinical Policy Approval Committee.

Foot doctors ID undiagnosed atrial fibrillation in patients with diabetes

Overall, the researchers found, 17% of study participants had undiagnosed AFib.

Humana agrees to take second look at panned payment change labeling PET/CT as ‘investigational’

The American Society of Nuclear Cardiology recently met with the Louisville, Kentucky, insurer, which shared an openness to reviewing a recent coverage determination.

Marijuana users with heart rhythm issues risk a ‘devastating outcome’

Marijuana users with a cardiac arrhythmia may face a heightened risk of in-hospital mortality, new research suggests.

Cardiologists join fight for better MIPS transparency

The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions joined dozens of other U.S. healthcare groups to request more clarity and better communication from CMS when it comes to MIPS updates.

Red meat linked to heart damage—expert says it ‘seems sensible’ to limit intake

Researchers relied on imaging data from nearly 20,000 UK Biobank participants to reach their conclusion.

Cardiology Associations

SCAI pushes for better radiation protection in cath labs

Tracking major trends and clinical research in acute coronary syndrome care

Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves

AI-based coronary plaque evaluations highlight elevated heart risks in women

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials